NEW YORK (GenomeWeb News) - The Genetic Association Information Network, a public and private partnership, will use Affymetrix's Genome-Wide Human SNP Array 6.0 in genomic studies of schizophrenia and bipolar disorder, Affy said today.
 
GAIN is run by the Foundation for the National Institutes of Health, the National Institutes of Health, and Pfizer Global Research and Development.
 
Affy said GAIN scientists will use the Human SNP 6.0 to analyze eight thousand samples from various ethnicities.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.